Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Tozasertib |
EINECS | N/A |
CAS No. | 639089-54-6 | Density | 1.4 g/cm3 |
PSA | 127.37000 | LogP | 3.65210 |
Solubility | N/A | Melting Point |
N/A |
Formula | C23H28N8OS | Boiling Point | N/A |
Molecular Weight | 464.594 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Cyclopropanecarboxylicacid N-[4-[[4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl]sulfanyl]phenyl]amide;MK 0457;VX 680; |
Article Data | 4 |
IUPAC name: N-[4-[4-(4-Methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl] cyclopropanecarboxamide
Molecular Formula: C23H28N8OS
Molecular Weight: 464.59 g/mol
Index of Refraction: 1.69
Surface Tension: 78.9 dyne/cm
Density: 1.37 g/cm3
Following is the structure of Tozasertib (CAS NO.639089-54-6):
Tozasertib (CAS NO.639089-54-6) is a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth. It is mainly used to treat blood cancer, colon cancer and milk.
Tozasertib , its cas register number is 639089-54-6. It also can be called N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide ; MK 0457 ; and VX 680 . And its classification code is antineoplastic agents.